Weijun Qin

3.2k total citations
97 papers, 2.2k citations indexed

About

Weijun Qin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Weijun Qin has authored 97 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Pulmonary and Respiratory Medicine and 21 papers in Immunology. Recurrent topics in Weijun Qin's work include Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Epigenetics and DNA Methylation (10 papers). Weijun Qin is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Epigenetics and DNA Methylation (10 papers). Weijun Qin collaborates with scholars based in China, United States and Australia. Weijun Qin's co-authors include Ruicong Wang, Qian Zhu, Qi Chen, Yan Liu, Jianlin Yuan, Xiaojian Yang, Weihong Wen, Donghui Han, Angang Yang and Zhi‐Nan Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weijun Qin

91 papers receiving 2.2k citations

Peers

Countries citing papers authored by Weijun Qin

Since Specialization

Citations

This map shows the geographic impact of Weijun Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Qin more than expected).

Fields of papers citing papers by Weijun Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijun Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Qin. The network helps show where Weijun Qin may publish in the future.

Co-authorship network of co-authors of Weijun Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Qin. A scholar is included among the top collaborators of Weijun Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Qin. Weijun Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer 2025 ·Cancer Research ·Jun Jiang, (unknown), Chao Xu, Limin He, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tong Lü, (unknown), Jingliang Zhang, (unknown), (unknown), Changhong Shi, Weihong Wen, Rui Zhang, Donghui Han, Weijun Qin	1
2	Relationship between alcohol use and overactive bladder disease: a cross-sectional study of the NHANES 2005–2016 2025 ·Frontiers in Public Health ·Yixin Zhang, Weijun Qin	2
3	YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer 2024 ·Cancer Research ·(unknown), Tong Lü, Donghui Han, (unknown), (unknown), Chao Xu, (unknown), (unknown), (unknown), Zhihao Hu, (unknown), (unknown), (unknown), Jingliang Zhang, (unknown), Changhong Shi, Weihong Wen, (unknown), Weijun Qin	28
4	Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA 2024 ·Clinical Cancer Research ·(unknown), (unknown), Lorenzo Gerratana, Andrew A. Davis, Paolo D’Amico, Akhil Chawla, Saya Jacob, Youbin Zhang, Jianhua Jiao, Weijun Qin, Carolina Reduzzi, Lisa Flaum, Ami N. Shah, William J. Gradishar	2
5	Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8⁺ T cell infiltration 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Tong Lü, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Donghui Han, (unknown), Weijun Qin, Weihong Wen	6
6	Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches 2023 ·Theranostics ·Shiqi Lu, (unknown), (unknown), Keying Zhang, (unknown), (unknown), Donghui Han, (unknown), (unknown), Fa Yang, Weijun Qin, Weihong Wen	9
7	CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation 2023 ·BMC Cancer ·Shiqi Lu, Tong Lü, Jiayu Zhang, (unknown), (unknown), Donghui Han, Keying Zhang, Chao Xu, Shaojie Liu, Weijun Qin, Fa Yang, Weihong Wen	8
8	NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling 2023 ·BMC Cancer ·(unknown), (unknown), (unknown), Jingliang Zhang, Shichao Han, Guohui Wang, Ruochen Qi, Xiaoyan Zhang, Fuli Wang, Jianlin Yuan, (unknown), (unknown), Weijun Qin	22
9	Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma 2023 ·Cancer Immunology Immunotherapy ·Tong Lü, Jiayu Zhang, Shiqi Lu, Fa Yang, (unknown), (unknown), (unknown), Shaojie Liu, Chao Xu, Donghui Han, Bo Yang, Weihong Wen, Weijun Qin, Lijun Yang	9
10	Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study 2023 ·Advances in Therapy ·Hongfan Zhao, Zhicheng Xu, Chengbin Li, Tong Xu, Jingliang Zhang, Jianhua Jiao, Bo Yang, (unknown), (unknown), Weijun Qin, Yuming Jing	2
11	Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities 2022 ·Frontiers in Oncology ·Xue Qin, Jingliang Zhang, Jianhua Jiao, Weijun Qin, Xiaojian Yang	30
12	Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer 2022 ·Scientific Reports ·Shiyuan Peng, (unknown), Fa Yang, Chao Xu, Hongji Li, Shiqi Lu, Jingliang Zhang, Jianhua Jiao, Donghui Han, Changhong Shi, (unknown), Angang Yang, Keying Zhang, Weihong Wen, Weijun Qin	6
13	PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt 2021 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Changjiang Yu, (unknown), (unknown), (unknown), Longlong Zhang, Fuli Wang, Fei Liu, Lijun Yang, Weijun Qin, Xiaojian Yang	10
14	CD248+ Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma 2021 ·Frontiers in Oncology ·Chao Xu, Keying Zhang, Fa Yang, Xiang Zhou, Shaojie Liu, Yu Li, (unknown), Xiaolong Zhao, Tong Lü, Shiqi Lu, (unknown), Hongji Li, Donghui Han, Weihong Wen, Weijun Qin	18
15	A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer 2019 ·Molecular Cancer Therapeutics ·Jieheng Wu, Donghui Han, Shengjia Shi, Qiang Zhang, Guoxu Zheng, Ming Wei, (unknown), Guodong Li, Fa Yang, Dian Jiao, (unknown), Lingling Zhang, Angang Yang, Aizhi Zhao, Weijun Qin, Weihong Wen	10
16	Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jingliang Zhang, Shuai Shao, (unknown), (unknown), Bo Yang, Donghui Han, Yu Li, (unknown), Wei Song, (unknown), Jing Zhang, Fei Kang, Weijun Qin, Jing Wang	46
17	Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer 2017 ·Scientific Reports ·Guangguo Tan, Haibo Wang, Jianlin Yuan, Weijun Qin, Xin Dong, Hong Wu, Ping Meng	43
18	PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth 2013 ·Cancer Letters ·(unknown), (unknown), Na Liu, Zhangyan Guo, Guodong Wang, Jia Zheng, Ming Wei, He Wang, Angang Yang, Weijun Qin, Weihong Wen	31
19	Research and development of Internet of things service platform based on REST-style architecture 2012 ·Computer Engineering and Applications Journal ·(unknown), Ruicong Wang, (unknown), Weijun Qin	2
20	Heparanase promotes bone destruction and invasiveness in prostate cancer 2008 ·Cancer Letters ·Zhou Yu, Bin Song, Weijun Qin, Geng Zhang, Rui Zhang, Qi Luan, Tiejun Pan, Angang Yang, He Wang	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact